Biodisin tells Studio Aperto about the BSL4 project at the Spallanzani Institute in Rom

[PRESS REVIEW]

The Studio Aperto interview with Roberto Franzoi, CEO of Biodisin: he talks about the assignment received by the Government for the design, manufacture and testing of a BSL4 (Biosafety Level 4), the SARS bioterrorism hospital at the Institute Spallanzani in Rome, the only one in Italy and one of the 18 currently active BSL4 hospitals in the world.

Watch the news report:

DEAR VISITOR

In accordance with the guidelines provided by the Ministry of Health regarding health advertising relating to medical devices, we inform you that access to this area of the site is intended for professional healthcare professionals.